Skip to main content
LCTX logo

LCTX · Lineage Cell Therapeutics, Inc. · Held by Funds

Track LCTX — free
$0.77 -0.05 (-5.87%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$195.26M
Shares
252.95M
Volume · Nov 20 2.04M Avg daily vol (3M) 1.63M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of LCTX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 8.06% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 1.46% 3,698,367
Index ETFs 6.60% 16,699,345
Active ETFs 0.00% 0
Active funds 0.27% 675,738
Unclassified 0.00% 0
All registered funds 8.33% 21,073,450
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding LCTX

77 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 77 positions
Key facts CIK 876343 CUSIP 53566P109 13F (30d) 146 filings 122 filers Visit website Investor relations